TRDA
vs
ABBV
TRDA
ABBV
Over the past 12 months, TRDA has underperformed ABBV, delivering a return of -16% compared to the ABBV's +15% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
TRDA
ABBV
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Entrada Therapeutics Inc
NASDAQ:TRDA
|
10.82
USD
|
|||||
|
Abbvie Inc
NYSE:ABBV
|
218.53
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
TRDA, ABBV
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Entrada Therapeutics Inc
Revenue
|
|||||||||||
|
Abbvie Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
TRDA, ABBV
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Entrada Therapeutics Inc
NASDAQ:TRDA
|
|||||||||
|
Abbvie Inc
NYSE:ABBV
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Entrada Therapeutics Inc | ||||
|
Abbvie Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
TRDA, ABBV
Performance Gap
TRDA, ABBV
Performance By Year
TRDA, ABBV
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.